Similar to Fuchs’s study [16], we found that both ≥50 and < 50% mucinous tumors showed similar molecular features with more frequent BRAF or KRAS mutations in comparison to tumors without mucinous component; this distinct molecular profile has no correlation with amount of mucinous component in the tumors as long as the mucin is more than 5%. Here, MUC5AC is linked to mucinous neoplasm.